Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Segmental Reporting Presentation

18 Jan 2018 07:00

RNS Number : 1913C
Ocado Group PLC
18 January 2018
 

 

 

 

OCADO GROUP PLC

 

18 January 2018

 

SEGMENTAL REPORTING PRESENTATION

 

As previously announced, Ocado Group will be introducing segmental reporting at the full year results on 6 February 2018. In light of that, the Group will today host a presentation at 3.30pm UK time, providing historic financials for FY2016, to enable analysts and investors to prepare their models accordingly.

 

No new material information will be disclosed and Ocado will not be commenting on current trading.

 

The presentation will be hosted by Duncan Tatton-Brown, CFO, at Goldman Sachs, Rooms G&H on River Court 7, 120 Fleet Street, EC4A 2BE and webcast live at the following link; https://3xscreen.videosync.fi/2018-01-18-segmental-reporting. A copy of the presentation will be available on http://www.ocadogroup.com/investors/reports-and-presentations/2017.aspx alongside the webcast.

 

END

 

Contacts

David Shriver, Director of Communications, on 01707 228 000

Michelle Clarke or Susanna Voyle at Tulchan Communications on 020 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGMMNNMGRZM
Date   Source Headline
2nd Jun 20261:43 pmRNSDirector/PDMR Shareholding
1st Jun 20263:09 pmRNSTotal Voting Rights
29th May 20267:00 amRNSOcado Group & Asda to enter ecommerce partnership
28th May 20268:11 amRNSDirector Declaration
19th May 20269:26 amRNSDirector/PDMR Shareholding
19th May 20268:33 amRNSAdmission to Trading
1st May 202611:31 amRNSTotal Voting Rights
28th Apr 20263:53 pmRNSResult of AGM
20th Apr 202611:07 amRNSHolding(s) in Company
16th Apr 20264:05 pmRNSDirector/PDMR Shareholding
14th Apr 202611:25 amRNSAdmission to Trading
7th Apr 202612:54 pmRNSDirector/PDMR Shareholding
7th Apr 202610:51 amRNSHolding(s) in Company
1st Apr 202611:24 amRNSTotal Voting Rights
30th Mar 20263:54 pmRNSDirector/PDMR Shareholding
18th Mar 202610:22 amRNSHolding(s) in Company
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
5th Mar 202611:00 amRNSAnnual Financial Report and Notice of Meeting
3rd Mar 20262:59 pmRNSDirector/PDMR Shareholding
3rd Mar 20262:56 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:57 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSPreliminary Results
17th Feb 20263:19 pmRNSDirector/PDMR Shareholding
5th Feb 20263:50 pmRNSHolding(s) in Company
5th Feb 20263:23 pmRNSHolding(s) in Company
5th Feb 20268:29 amRNSHolding(s) in Company
3rd Feb 20266:09 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSDirector Declaration
2nd Feb 20264:40 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSUpdate on Sobeys Partnership
28th Jan 20264:26 pmRNSHolding(s) in Company
27th Jan 20264:57 pmRNSBlock Listing Interim Review
22nd Jan 20263:07 pmRNSHolding(s) in Company
20th Jan 20263:25 pmRNSHolding(s) in Company
16th Jan 20262:06 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSHolding(s) in Company
9th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 202610:46 amRNSTotal Voting Rights
30th Dec 20257:00 amRNSExclusivity with International Partners
30th Dec 20257:00 amRNSExclusivity with International Partners
23rd Dec 20254:03 pmRNSHolding(s) in Company
23rd Dec 20254:03 pmRNSHolding(s) in Company
16th Dec 202511:45 amRNSDirector/PDMR Shareholding
9th Dec 202510:23 amRNSRedemption of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.